Skip to main content
رجوع
WST logo

West Pharmaceutical Services, Inc.

جودة البيانات: 100%
WST
NYSE Healthcare Medical - Instruments & Supplies
KWD 247.02
▲ KWD 1.75 (0.71%)
القيمة السوقية: 17.79B
نطاق اليوم
KWD 242.75 KWD 250.00
نطاق 52 أسبوعًا
KWD 187.43 KWD 322.34
حجم التداول
705,467
متوسط 50 يوم / 200 يوم
KWD 246.84 / KWD 252.44
الإغلاق السابق
KWD 245.27

Quick Summary

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (631 نظير)

المقياس السهم وسيط القطاع
P/E 36.0 0.2
P/B 5.6 3.0
ROE % 16.9 3.5
Net Margin % 16.1 3.8
Rev Growth 5Y % 2.1 9.7
D/E 0.1 0.2

السعر المستهدف للمحللين

Hold
KWD 303.33 +22.8%
Low: KWD 265.00 High: KWD 340.00
مكرر الربحية المستقبلي
30.81
ربحية السهم المستقبلية
KWD 8.02
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
3.25B

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2030 KWD 11.36
KWD 11.20 – KWD 11.51
4.03B 1
FY2029 KWD 11.11
KWD 10.95 – KWD 11.26
3.93B 1
FY2028 KWD 10.14
KWD 9.57 – KWD 10.70
3.69B 2

Earnings Surprises

Last 8 quarters
Quarter Est. EPS Actual EPS Surprise
2026-02-12 KWD 1.83 KWD 2.04 +11.5%
2025-10-23 KWD 1.68 KWD 1.96 +16.7%
2025-07-24 KWD 1.51 KWD 1.84 +21.9%
2025-04-24 KWD 1.22 KWD 1.45 +18.9%
2025-02-13 KWD 1.71 KWD 1.82 +6.4%
2024-10-24 KWD 1.50 KWD 1.85 +23.3%
2024-07-25 KWD 1.74 KWD 1.52 -12.6%
2024-04-25 KWD 1.26 KWD 1.56 +23.8%

Dividend History

7 yr streak

Yield

0.00%

Payout Ratio

0.12%

Growth (3Y)

5.20%

Growth (5Y)

5.51%

Ex-Date Payment Date Amount Yield
Apr 29, 2026 May 06, 2026 KWD 0.22 0.35%
Jan 28, 2026 Feb 04, 2026 KWD 0.22 0.36%
Nov 12, 2025 Nov 19, 2025 KWD 0.22 0.31%
Jul 30, 2025 Aug 06, 2025 KWD 0.21 0.34%
Apr 30, 2025 May 07, 2025 KWD 0.21 0.39%
Feb 07, 2025 Feb 11, 2025 KWD 0.21 0.26%
Nov 13, 2024 Nov 20, 2024 KWD 0.21 0.24%
Jul 31, 2024 Aug 07, 2024 KWD 0.20 0.26%
Apr 23, 2024 May 01, 2024 KWD 0.20 0.20%
Jan 30, 2024 Feb 07, 2024 KWD 0.20 0.21%
Nov 07, 2023 Nov 15, 2023 KWD 0.20 0.23%
Jul 25, 2023 Aug 02, 2023 KWD 0.19 0.20%
Apr 25, 2023 May 03, 2023 KWD 0.19 0.21%
Jan 24, 2023 Feb 01, 2023 KWD 0.19 0.29%
Nov 08, 2022 Nov 16, 2022 KWD 0.19 0.33%
Jul 19, 2022 Aug 03, 2022 KWD 0.18 0.24%
Apr 19, 2022 May 04, 2022 KWD 0.18 0.19%
Jan 18, 2022 Feb 02, 2022 KWD 0.18 0.19%
Nov 09, 2021 Nov 17, 2021 KWD 0.18 0.17%
Jul 20, 2021 Aug 04, 2021 KWD 0.17 0.18%

النقاط الرئيسية

Revenue grew 2.08% annually over 5 years — modest growth
ROE of 16.85% — decent returns on equity
Net margin of 16.06% shows strong profitability
Debt/Equity of 0.13 — conservative balance sheet
Generating 468.90M in free cash flow
P/E of 36.04 — premium valuation

النمو

Revenue Growth (5Y)
2.08%
Revenue (1Y)6.26%
Earnings (1Y)0.20%
FCF Growth (3Y)6.36%

الجودة

Return on Equity
16.85%
ROIC12.89%
Net Margin16.06%
Op. Margin20.09%

الأمان

Debt / Equity
0.13
Current Ratio3.02
Interest Coverage1029.00

التقييم

P/E Ratio
36.04
Forward P/E30.81
P/B Ratio5.60
EV/EBITDA28.21
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 6.26% Revenue Growth (3Y) 2.06%
Earnings Growth (1Y) 0.20% Earnings Growth (3Y) -8.79%
Revenue Growth (5Y) 2.08% Earnings Growth (5Y) -7.06%
Profitability
Revenue (TTM) 3.07B Net Income (TTM) 493.70M
ROE 16.85% ROA 11.56%
Gross Margin 35.89% Operating Margin 20.09%
Net Margin 16.06% Free Cash Flow (TTM) 468.90M
ROIC 12.89% FCF Growth (3Y) 6.36%
Safety
Debt / Equity 0.13 Current Ratio 3.02
Interest Coverage 1029.00
Dividends
Dividend Yield 0.00% Payout Ratio 0.12%
Dividend Growth (3Y) 5.20% Dividend Growth (5Y) 5.51%
Consecutive Div Years 7 yrs
Valuation
P/E Ratio 36.04 Forward P/E 30.81
P/B Ratio 5.60 P/S Ratio 5.79
PEG Ratio 34.00 Forward PEG N/A
EV/EBITDA 28.21 Fwd EV/EBITDA 19.57
Forward P/S 5.48 Fwd Earnings Yield 3.25%
FCF Yield 2.64%
Market Cap 17.79B Enterprise Value 17.42B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 3.07B 2.89B 2.95B 2.89B 2.83B
Net Income 493.70M 492.70M 593.40M 585.90M 661.80M
EPS (Diluted) 6.80 6.69 7.88 7.73 8.67
Gross Profit 1.10B 1.00B 1.13B 1.14B 1.17B
Operating Income 617.40M 594.60M 710.90M 763.50M 758.70M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 4.27B 3.64B 3.83B 3.62B 3.31B
Total Liabilities 1.09B 961.10M 948.50M 931.90M 978.40M
Shareholders' Equity 3.18B 2.68B 2.88B 2.68B 2.34B
Total Debt 416.70M 305.30M 309.00M 317.90M 325.30M
Cash & Equivalents 791.30M 484.60M 853.90M 894.30M 762.60M
Current Assets 1.98B 1.54B 1.94B 1.92B 1.74B
Current Liabilities 654.90M 550.40M 671.80M 519.00M 594.10M